Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ABBOTT LABORATORIES Hits Forecast Price Target, Generating 13.34% Profit for Investors

February 05, 2025

ABBOTT LABORATORIES, a global healthcare company, has recently reached its forecast price target of 131.45 $ as predicted by QuantWave on 2024-11-19. This successful forecast has resulted in a profit of 13.34% for investors who followed the long signal provided by the automated forecasting platform.

The stock was trading at 115.98 $ when the signal was issued, and it took just over two months for ABBOTT LABORATORIES to achieve the forecasted target price. This price movement reflects a positive momentum in the market, driven by various factors such as strong earnings reports, innovative product developments, and overall investor sentiment towards the healthcare sector.

QuantWave's accurate prediction for ABBOTT LABORATORIES showcases the platform's advanced analytics and forecasting capabilities. By leveraging quantitative models and machine learning algorithms, QuantWave provides users with valuable insights into stock price movements, helping them make informed investment decisions.

For investors seeking potential profits and market opportunities, QuantWave offers a wide range of stock predictions that can guide their trading strategies. Additionally, exploring QuantSchool's educational resources can provide a deeper understanding of the investment framework behind QuantWave's forecasting system, enabling users to generate consistent income in their trading endeavors.

With ABBOTT LABORATORIES hitting its forecast price target with a profit margin of 13.34%, investors can continue to rely on QuantWave for accurate and reliable predictions in the ever-changing financial markets.
If you want to leave a comment, then you need Login or Register





Other data for ABT

Related data

ABTAugust 9, 2025Abbott Laboratories NYSE:ABT Earnings Are Of Questionable Quality  ~1 min.

Abbott Laboratories recently reported their second quarter 2025 earnings, with EPS exceeding expectations....


ABTJune 5, 2025Abbott Laboratories ABT is Attracting Investor Attention: Here is What You Should Know  ~1 min.

Abbott Laboratories (ABT) has been making waves in the healthcare sector, attracting attention from investors around the globe....


ABTMarch 18, 2025Abbott Laboratories Continues to Drive Growth in the Healthcare Sector  ~2 min.

Abbott Laboratories (ABT) has emerged as a top player in the healthcare industry, making it an attractive stock for long-term investors....


ABTMarch 17, 2025Abbott Laboratories: A Leader in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) is a renowned healthcare company that has caught the attention of investors and industry experts alike....


ABTMarch 16, 2025Abbott Laboratories: Breaking New Ground in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making waves in the healthcare industry with its groundbreaking innovations....


ABTMarch 15, 2025Abbott Laboratories: A Healthcare Stock With Long-Term Investment Potential  ~2 min.

Abbott Laboratories (NYSE:ABT) is a renowned healthcare company that has been delivering groundbreaking medical technologies and products for decades....


ABTFebruary 26, 2025Abbott Laboratories Continues to Deliver Strong Earnings Growth  ~2 min.

Abbott Laboratories, a leading global healthcare company, has reported steady growth in earnings over the past five years....


ABTFebruary 22, 2025Abbott Laboratories: A Rising Star in the Pharmaceutical Industry  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making significant progress in the pharmaceutical industry, positioning itself as one of the best drug stocks to buy now....


ABTFebruary 21, 2025Abbott Laboratories NYSE:ABT: A Leading Drug Stock with Promising Future  ~1 min.

Abbott Laboratories, a renowned pharmaceutical company, has emerged as one of the best drug stocks to invest in....


ABTFebruary 21, 2025ABBOTT LABORATORIES Stock Hits Price Target with 16.11% Profit: QuantWave Forecast Success  ~2 min.

On December 2, 2024, QuantWave, the automated forecasting platform, issued a long signal for ABBOTT LABORATORIES stock when it was trading at 115.66 $....


ABTFebruary 20, 2025ABBOTT LABORATORIES Stock Hits Price Target Forecast with 15.12% Profit, QuantWave Analysis Shows Strong Predictive Power  ~2 min.

ABBOTT LABORATORIES (NYSE: ABT) investors reaped substantial gains as the stock price hit the forecasted target of 132.56 $ on February 20, 2025, resulting in a profit of 15.12%....


ABTFebruary 5, 2025ABBOTT LABORATORIES Stock Hits Price Target Forecast with 14.01% Profit: QuantWave Analysis  ~1 min.

Abbott Laboratories' stock recently achieved the price target forecast set by QuantWave, resulting in a profit of 14.01% for investors. The forecast signal date was November 12, 2024, with a price of 114.78$....


ABTOctober 12, 2023ABBOTT LABORATORIES Hits Forecast Price Target with 10.91% Profit, Confirming QuantWave's Accuracy  ~2 min.

Abbott Laboratories (NYSE: ABT) recently achieved the forecast price target set by QuantWave, signaling a profitable short position for investors....


ABTFebruary 21, 2024ABBOTT LABORATORIES Hits Price Target Forecast with 11.61% Profit  ~1 min.

QuantWave, an automated forecasting platform, successfully predicted the price movement of ABBOTT LABORATORIES stock, achieving an 11.61% profit on the forecasted long position....


ABTFebruary 5, 2025ABBOTT LABORATORIES Hits Price Target Forecast with 14.54% Profit  ~1 min.

On November 15, 2024, QuantWave's automated forecasting platform generated a long signal for ABBOTT LABORATORIES with the stock trading at 114.76 $....